Mesoblast Limited (ASX:MSB) Achieves FDA Approval for RYONCIL
Mesoblast Limited announces FDA approval of RYONCIL, the first MSC therapy for children with steroid-refractory acute graft versus host disease.

Mesoblast Limited announces FDA approval of RYONCIL, the first MSC therapy for children with steroid-refractory acute graft versus host disease.
Geopacific Resources announces a $40 million entitlement offer to enhance its Woodlark Gold Project through extensive drilling and studies.
Antipa Minerals Ltd raises A$16 million through an equity placement to advance its Minyari Dome Project and strengthen its balance sheet.
Black Canyon Limited (ASX:BCA) has issued a trading halt pending an announcement regarding a proposed capital raise.
Woodside Energy Group Ltd (ASX:WDS) announces an asset swap with Chevron to streamline its portfolio and enhance cash flow.
Peninsula Energy has commenced uranium production at its Lance Projects, marking a milestone in its journey as an independent producer.
Australian Pacific Coal Limited has successfully conducted its first coal sales from the Dartbrook coal mine, marking a pivotal milestone for the company.
AKORA Resources (ASX: AKO) reports substantial low-grade iron intercepts from the Satrokala Project, guiding future exploration.
Orthocell submits its FDA application for Remplirâ„¢, targeting the US nerve repair market, with clearance expected by April 2025.
Elders Limited outlines key financial results and strategic initiatives during its 2024 AGM, marking a resilient outlook for FY25.